The risk for new-onset or recurrent AF was not increased among older adult patients with preexisting conditions following RSV vaccination.

Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...

CI: confidence interval; COPD: chronic obstructive pulmonary disease; NA: not applicable. a Rate ratio and 95% confidence interval obtained from a Poisson regression analysis adjusted for sex, 5 ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine ...

An American Samoa epidemiologist has extended the closure of daycare centres in the territory due to respiratory syncytial virus (RSV).

A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more likely among people with other health issues and ...

Hospitalization rates from respiratory syncytial virus (RSV) infection rose with age. Also, hospitalizations were more likely among nursing home residents and older adults with other health issues, ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to protect adults aged 60 years and older against lower ...

Get Instant Summarized Text (Gist) In Spain, RSV hospitalization rates among older adults increase with age and are higher in those with certain health conditions or living in nursing homes. The ...